Ennett, Ribisl publish study on retailers’ views on tobacco point-of-sale policies

October 27, 2015

UNC Lineberger researchers Susan Ennett, PhD, professor and vice chair for academic affairs at the UNC Gillings School of Global Public Health, and Kurt Ribisl, PhD, professor, were authors on a study published in BMC Public Health that documented retailer opinions about tobacco control policies at the point of sale.

Finding could help predict whether breast cancer will spread to the brain

October 26, 2015

A study co-led by scientists at The Institute of Cancer Research, London, and the University of Wisconsin Carbone Cancer Center, in collaboration with UNC Lineberger Comprehensive Cancer Center researcher Charles M. Perou found that women whose breast cancer had begun to spread and who tested positive in the αB-crystallin test were three times more likely to have disease that spread to the brain than those who tested negative.

UNC Cancer Care: Lifting Patients Up

October 19, 2015

In the recent U.S. News and World Report rankings of America’s Best Hospitals, UNC Hospitals was nationally ranked in five of the 16 specialties. In this series by UNC School of Medicine, a closer look is taken at these specialties to learn more about what makes them so outstanding.

Study by UNC Lineberger scientist details role of tumor suppressor

October 15, 2015

UNC Lineberger Comprehensive Cancer Center researchers are working to better understand the cell-to-cell signaling that can cause precancerous polyps in the colon when signaling goes awry. In a study published in the open-access journal eLife, they describe the role of a key tumor suppressor protein called APC in helping to keep cells in the colon crypts from growing out of control.

Tom and Nancy Chewning: Looking at cancer in a whole new light

October 15, 2015

After Tom and Nancy Chewning’s daughter, Wilson, was diagnosed with breast cancer, they began to research the best treatment options for her. Their search led them to UNC Lineberger and Dr. Lisa Carey. Now with Wilson cancer-free, the Chewnings are investing in the Dr. Lisa Carey Fund for Breast Cancer Innovations so that others may also benefit from the most cutting-edge breast cancer research and treatment.